Feed NXTCL.ST
NX
NextCell Pharma AB
NXTCL.ST · STO
1.01 kr +1.81% (+0.02 kr)
1M -3.85%
Market Cap 112.7M kr
P/E Ratio -
Div. Yield -
ROE 78.09%
Bulios Fair Price
1.08 kr
6.7% upside
Preț actual
1.01 kr
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile NXTCL.ST sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Piotroski F-Score Weak
0/9Valuation
41 /100
Fair P/B 2.23x
P/S 11.41x
P/FFO N/A
Growth
78 /100
Growing Book val. growth 16.86%
Rev. growth 25.08%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 423.10%
Gross margin 222.84%
FCF margin 562.30%
Quality
2 /100
Poor ROA 63.97%
ROIC 74.78%
Asset turnover 0.15x
Debt
69 /100
Low Int. coverage -19,749.90x
Debt/Equity 0.00x
Current ratio 5.16x
Stability
54 /100
Moderate EPS volatility 17.08%
Beta 0.73x
Profitable years 0
Întreabă StockBot despre NXTCL.ST
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mathias Svahn
Employees
24
Headquarters
Huddinge
Evenimente viitoare
27 AUG.
Earnings
Upcoming earnings report
26 NOV.
Earnings
Upcoming earnings report